Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chloé Rancoule1, Alexis Vallard2, Omar Jmour2

  • 1Département de radiothérapie, Institut de Cancérologie Lucien Neuwirth, 108 bis avenue Albert Raimond, BP60008, 42271 Saint Priest en Jarez cedex, France; Laboratoire de Radiobiologie Cellulaire et Moléculaire, CNRS UMR 5822, Institut de Physique Nucléaire de Lyon, IPNL, 69622 Villeurbanne, France.

Bulletin Du Cancer
|January 1, 2019
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of population-based cancer registry data to evaluate organized breast cancer screening programmes in Europe by mode of detection: a scoping review.

European journal of public health·2026
Same author

Development of an intervention theory for a mobile mammography unit research project for breast cancer screening.

Canadian journal of public health = Revue canadienne de sante publique·2026
Same author

Feasibility of <i>TP53</i>-Mutated ctDNA Monitoring in High-Grade Endometrial Cancer Using Routine NGS.

Cancers·2026
Same author

Effect of a mobile mammography unit on participation and equity in breast cancer screening: a cluster randomised trial in Normandy, France.

Breast (Edinburgh, Scotland)·2026
Same author

Germline DNA Repair and Immune-metabolic Alterations Suggest a Potentially Distinct Form of Early-onset Prostate Cancer in Men of African Descent.

European urology oncology·2025
Same author

Molecular profiling of endometrial cancer in Martinique reveals frequent CCNE1 amplification in poor prognosis tumors.

Scientific reports·2025
This summary is machine-generated.

Radiation therapy can stimulate the immune system, enhancing anti-cancer responses. Combining radiation therapy with immunotherapy shows promise, but clinical data and treatment optimization are needed for effectiveness.

Area of Science:

  • Oncology
  • Immunology
  • Radiation Oncology

Background:

  • The immune system plays a crucial role in cancer development and response to therapy.
  • Radiation therapy is increasingly recognized for its ability to stimulate anti-tumor immune responses.
  • Combining radiation therapy with immunotherapy is a promising strategy in oncology.

Purpose of the Study:

  • To explore the synergistic potential of combining radiation therapy and immunotherapy.
  • To highlight the biological rationale and current clinical evidence for immuno-radiotherapy.
  • To identify challenges and areas for optimization in immuno-radiotherapy approaches.

Main Methods:

  • Review of preclinical data demonstrating the immuno-stimulatory effects of radiation therapy.
Keywords:
Abscopal effectEffet abscopalImmune systemImmunotherapiesImmunothérapiesRadiation therapyRadiations ionisantesSystème immunitaire

Related Experiment Videos

  • Analysis of existing clinical data on the combination of radiation therapy and immunotherapy.
  • Discussion of ongoing and future clinical trials, including Phase III studies.

    • Main Results:

    • Preclinical studies provide a strong biological basis for combining radiation therapy and immunotherapy.
    • Clinical data supporting the efficacy and safety of immuno-radiotherapy is currently limited.
    • Optimization of treatment parameters (tumor characteristics, irradiation regimen, treatment plan) is crucial.

    Conclusions:

    • The combination of radiation therapy and immunotherapy holds significant potential for improving cancer treatment outcomes.
    • Further clinical trials are essential to establish optimal protocols and confirm efficacy.
    • Standardization of immuno-radiotherapy strategies is needed to maximize therapeutic benefits and ensure patient safety.